Attendance of the fourth (2008–2009) screening round of the Hungarian organized, nationwide breast cancer screening program

Boncz, I; Döbrőssy, Lajos; Péntek, Z; Kovács, Attila; Budai, András; Imre, László; Vajda, R; Sebestyén, Andor

doi:10.1556/oh.2013.29744

Cited by 7 publications

(6 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Several reasons can be attributed to this phenomenon. First, although breast cancer screening programs have been implemented for almost 20 years in Hungary, participation rates were still below 50% in the 2000s, which seems significantly lower than the ideal 70% required to achieve a significant impact on breast cancer mortality (43)(44)(45). In addition, a recent Hungarian cross-sectional study revealed significant knowledge gaps in the field of breast cancer screening recommendations among women.…”

Section: Discussionmentioning

confidence: 99%

Opposite trends in incidence of breast cancer in young and old female cohorts in Hungary and the impact of the Covid-19 pandemic: a nationwide study between 2011–2020

Kiss,

Kocsis,

Nikolényi

et al. 2023

Front. Oncol.

View full text Add to dashboard Cite

BackgroundThis nationwide study examined breast cancer (BC) incidence and mortality rates in Hungary between 2011–2019, and the impact of the Covid-19 pandemic on the incidence and mortality rates in 2020 using the databases of the National Health Insurance Fund (NHIF) and Central Statistical Office (CSO) of Hungary.MethodsOur nationwide, retrospective study included patients who were newly diagnosed with breast cancer (International Codes of Diseases ICD)-10 C50) between Jan 1, 2011 and Dec 31, 2020. Age-standardized incidence and mortality rates (ASRs) were calculated using European Standard Populations (ESP).Results7,729 to 8,233 new breast cancer cases were recorded in the NHIF database annually, and 3,550 to 4,909 all-cause deaths occurred within BC population per year during 2011-2019 period, while 2,096 to 2,223 breast cancer cause-specific death was recorded (CSO). Age-standardized incidence rates varied between 116.73 and 106.16/100,000 PYs, showing a mean annual change of -0.7% (95% CI: -1.21%–0.16%) and a total change of -5.41% (95% CI: -9.24 to -1.32). Age-standardized mortality rates varied between 26.65–24.97/100,000 PYs (mean annual change: -0.58%; 95% CI: -1.31–0.27%; p=0.101; total change: -5.98%; 95% CI: -13.36–2.66). Age-specific incidence rates significantly decreased between 2011 and 2019 in women aged 50–59, 60–69, 80–89, and ≥90 years (-8.22%, -14.28%, -9.14%, and -36.22%, respectively), while it increased in young females by 30.02% (95%CI 17,01%- 51,97%) during the same period. From 2019 to 2020 (in first COVID-19 pandemic year), breast cancer incidence nominally decreased by 12% (incidence rate ratio [RR]: 0.88; 95% CI: 0.69–1.13; 2020 vs. 2019), all-cause mortality nominally increased by 6% (RR: 1.06; 95% CI: 0.79–1.43) among breast cancer patients, and cause-specific mortality did not change (RR: 1.00; 95%CI: 0.86–1.15).ConclusionThe incidence of breast cancer significantly decreased in older age groups (≥50 years), oppositely increased among young females between 2011 and 2019, while cause-specific mortality in breast cancer patients showed a non-significant decrease. In 2020, the Covid-19 pandemic resulted in a nominal, but not statistically significant, 12% decrease in breast cancer incidence, with no significant increase in cause-specific breast cancer mortality observed during 2020.

show abstract

Section: Discussionmentioning

confidence: 99%

Opposite trends in incidence of breast cancer in young and old female cohorts in Hungary and the impact of the Covid-19 pandemic: a nationwide study between 2011–2020

Kiss,

Kocsis,

Nikolényi

et al. 2023

Front. Oncol.

View full text Add to dashboard Cite

show abstract

“…A szervezett népegészségügyi szűrési programokon való részvételi arányokat és a teljes lefedettség alakulását a két daganatféleség esetén korábban részletesen elemezték. Az emlőszűrés esetén az első 2002-2003-as szűrési ciklusban a részvételi arány 45,1%, a 2004-2005-ös ciklusban 37,2%, míg a következő két szűrési ciklusban 41% és 42,7% volt, ami elmaradt a WHO 70%-os célkitűzésétől [15][16][17][18]. A 45-65 éves női célpopulációban a szűrési (átszűrtség) és diagnosztikus (átvizsgáltság) emlőfelvétellel rendelkezők aránya (teljes lefedettség) az első szűrési ciklusban 53,5%-os, míg a következő ciklusokban 50,8%, 49,7% és 51,0% volt, tehát a 2002-2009-es időszakban érdemi változás nem történt [15][16][17][18].…”

Section: Eredeti Közleményunclassified

A magyarországi emlő- és méhnyakszűrés retrospektív vizsgálatának jellemzői a halálozási és megbetegedési adatok tükrében

Sárváry

Bálint²,

Gyulai

et al. 2019

Orvosi Hetilap

View full text Add to dashboard Cite

Introduction: The organized breast and cervical screening programs were implemented in the framework of public health program in Hungary in order to reduce breast cancer mortality by 30% and cervical cancer mortality by 60% in given age groups within 10 years by 2012. Aim: The aim of our study was to conduct a retrospective analysis of mortality and morbidity data and to evaluate the effectiveness of the implemented screening programs. Method: Descriptive statistical analysis was performed by age-standardized mortality and morbidity data between 1980 and 2015 with special regard to the period of 2002–2012. Results: Breast cancer mortality of women aged 45–64 reduced by 28.3%, the incidence reduced by 23.6% and the incidence of in situ carcinoma increased by 242% between 2002 and 2012. Cervical cancer mortality of women aged 25–64 years reduced by 25.5%, the incidence reduced by 21.2%, and the incidence of in situ carcinoma increased by 13.3% during 2002–2012. Conclusion: Although both breast cancer and cervical cancer mortality substantially decreased in Hungary, the decrease in cervical cancer did not reach the target value. Orv Hetil. 2019; 160(49): 1948–1956.

show abstract

“…The country has a long history of population-level breast cancer screening, having established the national programme in 2002 for women aged 45-65 years with a two-year screening interval [1] . Before the pandemic, the examination rate in the target population was between 45-60% depending on the age group [2] .…”

Section: Introductionmentioning

confidence: 99%

Effects of lower screening activity during the COVID-19 pandemic on breast cancer patient pathways: Evidence from the age cut-off of organized screening

et al. 2022

View full text Add to dashboard Cite

Attendance of the fourth (2008–2009) screening round of the Hungarian organized, nationwide breast cancer screening program

Abstract: In order to decrease the mortality due to breast cancer, the attendance rate of mammography screening programme should be increased. Orv. Hetil., 154(50), 1975-1983.

Cited by 7 publications

References 23 publications

Opposite trends in incidence of breast cancer in young and old female cohorts in Hungary and the impact of the Covid-19 pandemic: a nationwide study between 2011–2020

Opposite trends in incidence of breast cancer in young and old female cohorts in Hungary and the impact of the Covid-19 pandemic: a nationwide study between 2011–2020

A magyarországi emlő- és méhnyakszűrés retrospektív vizsgálatának jellemzői a halálozási és megbetegedési adatok tükrében

Effects of lower screening activity during the COVID-19 pandemic on breast cancer patient pathways: Evidence from the age cut-off of organized screening

Contact Info

Product

Resources

About